Minaris is a global cell and gene therapy (CGT) CDMO and multimodal biosafety testing organization. With more than 25 years of CGT development and manufacturing expertise and more than 40 years in biosafety testing, Minaris combines deep legacy experience with state-of-the-art GMP facilities.
Cooperation possibilities
Cell and gene therapy CDMO:
- Process Development
- Technology Transfer
- cGMP manufacturing
Biosafety Testing Services for Biologics, Vaccines, Cell & Gene therapies:
- Analytical development
- Biosafety testing
- Product Characterization
- https://minaris.com
- +1 215 218 71 00
- Send an email
- Delphine Caraguel
Some insights
- Research
- Engineering
- Quality Assurance
- Operations
- Program and Project Management
- Manager, Senior Manager, Director, Senior Director, VP
- Biotechnology Research
- Pharmaceutical Manufacturing
- Pharmaceuticals
- Biopharmaceuticals
Our Mission
Enabling Innovators.
Manufacturing and Testing Therapies.
Delivering Hope.
Our Vision
We empower innovators to realize bold scientific discoveries by delivering high-quality, life-changing therapies to patients worldwide - rapidly, reliably, and accessibly.
We are committed to helping clients advance their programs and increase patient access worldwide.
We deliver proven results across every phase of development, manufacturing and quality control.
We support innovators focusing on cell and gene therapy from preclinical development through commercial production. Our technical expertise, global infrastructure and end-to-end services ensure consistent delivery, efficient tech transfer and scalable manufacturing solutions.
Job Functions
Seniority levels
Industries